伯乐生命医学-B BIO.B
$379.50 +$0.00 (0.00%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $379.50 0.00%
开盘$0.00
昨收$379.50
当日区间$0.00 – $0.00
成交量9.00
市值$10.21B
市盈率（TTM）10.1
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$651.00M-0.1% YoY
营业利润$72.60M-5.8% YoY
净利润$371.40M+16.9% YoY
摊薄每股收益$13.85+18.7% YoY
自由现金流$66.70M-5.8% YoY
经营现金流$98.70M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率51.9%
营业利润率8.7%
净利率8.6%
净资产收益率3.1%
资产收益率2.2%
投入资本回报率2.3%
流动比率3.14
负债/资产比率30.0%
现金及投资$1.62B
总负债$1.34B
净现金（净负债）$281.70M
自由现金流/营收13.6%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $651.00M | $592.10M | $2.58B | $693.20M | $653.00M |
| 营业总收入 | $651.00M | $592.10M | $2.58B | $693.20M | $653.00M |
| 营业成本 | $305.20M | $282.70M | $1.24B | $348.00M | $309.60M |
| 毛利润 | $345.80M | $309.40M | $1.34B | $345.20M | $343.40M |
| 营业费用 | $273.20M | $275.30M | $1.12B | $291.30M | $279.50M |
| 销售及管理费用 | $212.00M | $212.40M | $844.30M | $221.00M | $206.80M |
| 研发费用 | $61.20M | $62.90M | $275.60M | $70.30M | $71.30M |
| 营业利润 | $72.60M | $34.10M | $218.60M | $53.90M | $63.90M |
| 非经营性利息净收入（支出） | $10.20M | $8.70M | $46.50M | $18.90M | $1.40M |
| 非经营性利息收入 | $22.30M | $21.00M | $95.50M | $31.00M | $13.70M |
| 非经营性利息支出 | $12.10M | $12.30M | $49.00M | $12.10M | $12.30M |
| 其他收入（支出） | $459.30M | -$732.60M | $730.40M | $856.40M | -$496.40M |
| 证券出售收益 | $458.50M | -$733.30M | $908.00M | $1.03B | -$491.40M |
| 其他非经营性收入（支出） | $800,000.00 | $700,000.00 | $1.20M | -$1.00M | $1.00M |
| 税前利润 | $542.10M | -$689.80M | $995.50M | $929.20M | -$431.10M |
| 税费 | $170.70M | -$162.70M | $235.60M | $209.20M | -$89.20M |
| 净利润 | $371.40M | -$527.10M | $759.90M | $720.00M | -$341.90M |
| 持续经营利润 | $371.40M | -$527.10M | $759.90M | $720.00M | -$341.90M |
| 归属母公司净利润 | $371.40M | -$527.10M | $759.90M | $720.00M | -$341.90M |
| 归属普通股股东净利润 | $371.40M | -$527.10M | $759.90M | $720.00M | -$341.90M |
| 基本每股收益 | $13.89 | -$19.55 | $27.87 | $26.69 | -$12.70 |
| 摊薄每股收益 | $13.85 | -$19.55 | $27.85 | $26.65 | -$12.70 |
| 资产减值损失 | – | – | $1.40M | $0.00 | $1.40M |
| 特殊收益（费用） | – | – | -$178.80M | -$172.80M | -$6.00M |
| -减：资本性资产减值 | – | – | $172.80M | – | – |
| -减：核销 | – | – | $6.00M | $0.00 | $6.00M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $10.25B | $9.79B | $10.58B | $10.58B | $9.70B |
| 流动资产合计 | $3.02B | $2.94B | $2.91B | $2.91B | $2.84B |
| 现金及现金等价物与短期投资 | $1.62B | $1.56B | $1.54B | $1.54B | $1.42B |
| -现金及现金等价物 | $517.00M | $507.20M | $529.80M | $529.80M | $395.80M |
| -短期投资 | $1.10B | $1.06B | $1.01B | $1.01B | $1.02B |
| 应收款 | $441.80M | $426.20M | $460.60M | $460.60M | $464.70M |
| -应收账款 | $441.80M | $426.20M | $460.60M | $460.60M | $464.70M |
| 预付资产 | $147.80M | $150.00M | $136.50M | $136.50M | $152.00M |
| 存货 | $780.60M | $770.50M | $740.70M | $740.70M | $783.20M |
| 其他流动资产 | $31.80M | $30.70M | $27.70M | $27.70M | $23.50M |
| 非流动资产合计 | $7.23B | $6.85B | $7.67B | $7.67B | $6.85B |
| 固定资产净值 | $671.90M | $689.40M | $709.90M | $709.90M | $720.50M |
| -固定资产原值 | $671.90M | $689.40M | $1.97B | $1.97B | $720.50M |
| 投资及预付款 | $5.72B | $5.31B | $6.10B | $6.10B | $5.06B |
| 商誉及其他无形资产 | $734.30M | $743.90M | $754.10M | $754.10M | $967.10M |
| -商誉 | $574.30M | $577.10M | $579.80M | $579.80M | $578.70M |
| -其他无形资产 | $160.00M | $166.80M | $174.30M | $174.30M | $388.40M |
| 其他非流动资产 | $101.70M | $102.80M | $102.70M | $102.70M | $109.00M |
| 负债合计 | $3.08B | $2.94B | $3.12B | $3.12B | $2.96B |
| 流动负债合计 | $961.30M | $917.00M | $517.00M | $517.00M | $522.30M |
| 应付款 | $217.70M | $178.00M | $165.60M | $165.60M | $173.60M |
| -应付账款 | $143.50M | $133.10M | $129.00M | $129.00M | $128.80M |
| -应付税款合计 | $74.20M | $44.90M | $36.60M | $36.60M | $44.80M |
| 一年内应计费用 | $150.50M | $148.40M | $172.30M | $172.30M | $182.80M |
| 短期债务及融资租赁负债 | $434.30M | $436.70M | $37.40M | $37.40M | $38.10M |
| -一年内到期债务 | $400.70M | $400.50M | $1.30M | $1.30M | $1.30M |
| -一年内到期融资租赁负债 | $33.60M | $36.20M | $36.10M | $36.10M | $36.80M |
| 其他流动负债 | $158.80M | $153.90M | $141.70M | $141.70M | $127.80M |
| 非流动负债合计 | $2.12B | $2.02B | $2.61B | $2.61B | $2.44B |
| 长期债务及融资租赁负债 | $936.10M | $941.50M | $1.35B | $1.35B | $1.36B |
| -长期债务 | $803.00M | $802.90M | $1.20B | $1.20B | $1.20B |
| -长期融资租赁负债 | $133.10M | $138.60M | $145.70M | $145.70M | $155.80M |
| 一年以上递延负债 | $982.20M | $881.80M | $1.06B | $1.06B | $872.60M |
| 其他非流动负债 | $198.50M | $198.40M | $197.80M | $197.80M | $207.50M |
| 股东权益合计 | $7.17B | $6.85B | $7.45B | $7.45B | $6.74B |
| 股东权益 | $7.17B | $6.85B | $7.45B | $7.45B | $6.74B |
| 股本 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $502.90M | $490.50M | $476.00M | $476.00M | $461.90M |
| 留存收益 | $8.02B | $7.65B | $8.18B | $8.18B | $7.46B |
| 减：库存股 | $1.08B | $1.05B | $1.01B | $1.01B | $1.01B |
| 不影响留存收益的损益 | -$271.30M | -$235.40M | -$189.10M | -$189.10M | -$166.80M |
| -累计折旧 | – | – | -$1.26B | -$1.26B | – |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $98.70M | $108.10M | $532.20M | $164.90M | $120.90M |
| 持续经营经营活动现金流净额 | $98.70M | $108.10M | $532.20M | $164.90M | $120.90M |
| 持续经营净利润 | $371.40M | -$527.10M | $759.90M | $720.00M | -$341.90M |
| 折旧、折耗与摊销 | $41.10M | $40.90M | $165.40M | $42.50M | $44.20M |
| 其他非现金项目 | -$8.70M | $9.60M | -$3.30M | -$10.90M | $3.40M |
| 营运资金变动 | $138.40M | -$168.50M | $272.40M | $254.10M | -$102.40M |
| -应收款变动 | -$17.60M | $30.80M | $19.60M | $3.90M | $4.20M |
| -存货变动 | -$7.80M | -$29.90M | $68.90M | $51.60M | $13.60M |
| -应付账款及应计费用变动 | $64.40M | -$600,000.00 | $1.40M | $12.30M | -$32.90M |
| -其他流动资产变动 | -$14.00M | -$4.80M | $12.20M | -$4.20M | $2.10M |
| -其他流动负债变动 | $4.60M | $2.00M | -$200,000.00 | $300,000.00 | -$1.00M |
| -其他营运资金变动 | $108.80M | -$166.00M | $170.50M | $190.20M | -$88.40M |
| 投资活动现金流净额 | -$66.70M | -$93.20M | -$189.70M | -$34.20M | -$43.00M |
| 持续经营投资活动现金流净额 | -$66.70M | -$93.20M | -$189.70M | -$34.20M | -$43.00M |
| 固定资产购置及出售净额 | -$32.10M | -$29.90M | -$157.50M | -$45.80M | -$31.70M |
| 投资购置及出售净额 | -$35.70M | -$63.30M | $186.30M | $11.60M | -$9.50M |
| 筹资活动现金流 | -$27.60M | -$44.00M | -$283.20M | $3.30M | -$52.50M |
| 持续经营筹资活动现金流净额 | -$27.60M | -$44.00M | -$283.20M | $3.30M | -$52.50M |
| 债务发行及偿还净额 | -$200,000.00 | -$100,000.00 | -$500,000.00 | -$200,000.00 | $0.00 |
| 普通股发行净额 | -$31.50M | -$47.80M | -$295.50M | $0.00 | -$53.40M |
| 股票期权行使所得 | $4.20M | $3.90M | $15.80M | $3.90M | $3.40M |
| 期末现金余额 | $518.80M | $509.00M | $532.20M | $532.20M | $398.20M |
| 现金净变动 | $4.40M | -$29.10M | $59.30M | $134.00M | $25.40M |
| 期初现金余额 | $509.00M | $532.20M | $489.80M | $398.20M | $371.70M |
| 汇率变动影响 | $5.40M | $5.90M | -$16.90M | $0.00 | $1.10M |
| 自由现金流 | $66.70M | $78.10M | $374.60M | $119.10M | $89.20M |
| 无形资产购置及出售净额 | – | – | $0.00 | $0.00 | – |
| 业务购买及出售净额 | – | – | -$218.50M | $0.00 | -$1.80M |
| 其他筹资费用净额 | – | – | -$3.00M | -$400,000.00 | -$2.50M |
暂无评论——快来第一个聊聊 BIO.B。
登录后参与讨论。